Buscar en
Revista de Psiquiatría y Salud Mental
Toda la web
Inicio Revista de Psiquiatría y Salud Mental Sex and substance use in first episode psychosis: Impact on clinical symptoms, p...
Información de la revista
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Original article
Disponible online el 1 de Junio de 2022
Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance
Visitas
12
Gemma Safonta,b,1, Marina Garrigab,c,1, Silvia Amorettib,c,d,e,f,g,
Autor para correspondencia
silvia.amoretti@vhir.org

Corresponding authors.
, Manuel J. Cuestah,i, Mara Parelladab,j, Ana González-Pintob,k, Daniel Bergéb,l, Roberto Rodriguez-Jimenezb,m, Alexandra Roldán Bejaranob,n, Salvador Sarrób,o, Ángela Ibáñezb,p, Judith Usallq, Miguel Gutiérrezb,r, Eduard Vietab,
Autor para correspondencia
evieta@clinic.cat

Corresponding authors.
, Belén Arranzs, Esther Berrocosob,t, Norma Verdolinic,2, Miguel Bernardod,2, 2EPS Group
a Department of Psychiatry, University Hospital Mutua Terrassa, University of Barcelona, Barcelona, Spain
b CIBERSAM, Spain
c Bipolar and Depressive Disorders Unit, Institute of Neurosciences, University of Barcelona, Barcelona, Spain
d Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Department of Medicine, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
e Department of Psychiatry, Hospital Universitari Vall d’Hebron, Barcelona, Spain
f Group of Psychiatry, Mental Health and Addictions, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
g Psychiatric Genetics Unit, Vall d’Hebron Research Institute (VHIR), Barcelona, Spain
h Department of Psychiatry, Complejo Hospitalario de Navarra, Pamplona, Spain
i IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
j Department of Child and Adolescent Psychiatry, Institute of Psychatry and Mental Health, Hospital General Universitario Gregorio Marañon, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain
k Department of Psychiatry, Araba University Hospital, Bioaraba Research Institute, Department of Neurociences, University of the Basque Country, Vitoria, Spain
l Hospital del Mar Medical research Institute (IMIM), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
m Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CogPsy Group, Universidad Complutense de Madrid (UCM), Madrid, Spain
n Psychiatry Department, Institut d’Investigació Biomèdica-SantPau (IIB-SANTPAU), Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
o FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain
p Department of Psychiatry, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain
q Parc Sanitari Sant Joan de Déu, Teaching, Research & Innovation Unit, Institut de Recerca Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
r Araba University Hospital, Bioaraba Research Institute, Vitoria, Spain
s Parc Sanitari Sant Joan de Deu, CIBERSAM, Barcelona, Spain
t Neuropsychopharmacology and Psychobiology Research Group, Department of Psychology, University of Cádiz, Instituto de Investigación e Innovación Biomédica de Cádiz, INiBICA, Hospital Universitario Puerta del Mar, Cádiz, Spain
Ver más
Este artículo ha recibido
Recibido 15 septiembre 2021. Aceptado 18 marzo 2022
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (5)
Table 1. Sex differences in sociodemographic, clinical, functional and cognitive characteristics.
Table 2. Sex differences in substance use.
Table 3. Main effects and interactions for the sociodemographic, clinical, functional and neurocognitive variables of current and non-current substance users.
Table 4. Main effects and interactions for the sociodemographic, clinical, functional and neurocognitive variables on lifetime and never substance users.
Table 5. Prediction of age at onset of psychosis.
Mostrar másMostrar menos
Material adicional (1)
Abstract
Introduction

Sex differences in first episode of psychosis (FEP) have been widely studied. However, the existence of controversial results may be attributable to not considering relevant factors such as substance use. Cannabis use is associated with an earlier age of onset of psychosis and rates of cannabis use are consistently higher among men. The main objective of this study was to analyze and describe sex differences while considering the presence of substance use and its potential role when predicting age at onset of psychosis.

Material and methods

A cross-sectional study of 223 non-affective FEP patients was performed. Participants were divided into “current substance users”, defined as those who reported having used a substance in the past 30 days, and those who did not as “not current substance users”. Descriptive analyses, general linear modeling and multiple regression modeling were used.

Results

In the current substance group, women were older, with an older age of onset, a better premorbid adjustment and a higher cognitive reserve while presenting less clinical severity, a better functioning and a better verbal memory performance in comparison with men. In males, but not in females, lifetime of cannabis use and accumulative lifetime substance use was associated with age of onset.

Conclusions

Clinical presentation of FEP varies by sex and especially when considering substance use. Our results suggest that early interventions need to be tailored to the different clinical needs of males and females and according to substance consumption in FEP.

Keywords:
Cannabis
Cognition
Cognitive reserve
First episode of psychosis
Functioning

Artículo

Opciones para acceder a los textos completos de la publicación Revista de Psiquiatría y Salud Mental
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Suscribirse
Suscribirse a:

Revista de Psiquiatría y Salud Mental

Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 19,34 €

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Opciones de artículo
Herramientas
Material suplementario
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos